CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-14 | Daglio David Angelo Jr. Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +15,677 | 15,677 | ||
| 2021-06-14 | Daglio David Angelo Jr. Director | Grant or award · Restricted Stock Unit Award | +7,585 | 7,585 | ||
| 2021-06-14 | Cooke Shane Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +15,677 | 15,677 | ||
| 2021-06-14 | Cooke Shane Director | Grant or award · Restricted Stock Unit Award | +7,585 | 7,585 | ||
| 2021-06-14 | ANSTICE DAVID W Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +15,677 | 15,677 | ||
| 2021-06-14 | ANSTICE DAVID W Director | Grant or award · Restricted Stock Unit Award | +7,585 | 7,585 | ||
| 2021-06-14 | Alva Emily Peterson Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +15,677 | 15,677 | ||
| 2021-06-14 | Alva Emily Peterson Director | Grant or award · Restricted Stock Unit Award | +7,585 | 7,585 | ||
| 2021-06-10 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Exercise or conversion | +13,500 | $16.55 | $223K | 88,097 |
| 2021-06-10 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Sale | −13,500 | $25.00 | $338K | 74,597 |
| 2021-06-10 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Exercise or conversion · Employee Stock Option (Right to Buy) | −13,500 | 14,000 | ||
| 2021-06-10 | DIXON WENDY L Director | Exercise or conversion | +25,000 | $18.21 | $455K | 66,300 |
| 2021-06-10 | DIXON WENDY L Director | Sale | −25,000 | $25.00 | $625K | 41,300 |
| 2021-06-10 | DIXON WENDY L Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2021-06-09 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | −882 | $24.60 | $22K | 0 |
| 2021-06-09 | Alva Emily Peterson Director | Grant or award · Restricted Stock Unit Award | +532 | 532 | ||
| 2021-06-09 | Alva Emily Peterson Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +1,115 | 1,115 | ||
| 2021-06-09 | Alva Emily Peterson Director | Grant or award · Restricted Stock Unit Award | +11,387 | 11,387 | ||
| 2021-06-09 | Alva Emily Peterson Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +22,759 | 22,759 | ||
| 2021-06-07 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Exercise or conversion | +1,250 | 1,250 |
Page 61 of 75 · 1,492 trades